Literature DB >> 16995389

Equilibrium in lung schistosomula sphingomyelin breakdown and biosynthesis allows very small molecules, but not antibody, to access proteins at the host-parasite interface.

Rashika El Ridi1, Hatem Tallima.   

Abstract

The mechanism by which lung-stage schistosomula expose proteins at the host-parasite interface to nutrient, but not antibody, uptake has been obscure. We have found that Schistosoma mansoni and Schistosoma haematobium larvae emerging from host lung at a pH of around 7.5, and fixed with diluted formaldehyde (HCHO), readily bind specific antibodies in indirect membrane immunofluorescence. Data on inhibitors and activators of parasite tegument-bound, magnesium-dependent, neutral sphingomyelinase (nSMase), and sphingomyelin biosynthesis inhibitors revealed that equilibrium in schistosomular sphingomyelin breakdown and biosynthesis prevents antibody binding, yet permits access of small HO-CH2-OH polymers to interact with and cross-link proteins at the host-parasite interface, allowing for their serological visualization.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16995389     DOI: 10.1645/GE-745R1.1

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  14 in total

1.  In vitro and in vivo activities of arachidonic acid against Schistosoma mansoni and Schistosoma haematobium.

Authors:  Rashika El Ridi; Marwa Aboueldahab; Hatem Tallima; Mohamed Salah; Noha Mahana; Samia Fawzi; Shadia H Mohamed; Omar M Fahmy
Journal:  Antimicrob Agents Chemother       Date:  2010-05-17       Impact factor: 5.191

2.  Silencing Retinoid X Receptor Alpha Expression Enhances Early-Stage Hepatitis B Virus Infection In Cell Cultures.

Authors:  Mei Song; Yinyan Sun; Wenhui Li; Ji Tian; Wenhui He; Guangwei Xu; Zhiyi Jing
Journal:  J Virol       Date:  2018-03-28       Impact factor: 5.103

3.  Single oral fixed-dose praziquantel-miltefosine nanocombination for effective control of experimental schistosomiasis mansoni.

Authors:  Maha M Eissa; Mervat Z El-Azzouni; Labiba K El-Khordagui; Amany Abdel Bary; Riham M El-Moslemany; Sara A Abdel Salam
Journal:  Parasit Vectors       Date:  2020-09-15       Impact factor: 3.876

4.  Efficacy and safety of arachidonic acid for treatment of Schistosoma mansoni-infected children in Menoufiya, Egypt.

Authors:  Sahar Selim; Ola El Sagheer; Azza El Amir; Rashida Barakat; Kevin Hadley; Maaike J Bruins; Rashika El Ridi
Journal:  Am J Trop Med Hyg       Date:  2014-09-22       Impact factor: 2.345

Review 5.  Novel therapeutic and prevention approaches for schistosomiasis: review.

Authors:  Rashika A F El Ridi; Hatem A-M Tallima
Journal:  J Adv Res       Date:  2012-06-23       Impact factor: 10.479

6.  Efficacy and safety of arachidonic acid for treatment of school-age children in Schistosoma mansoni high-endemicity regions.

Authors:  Rashida Barakat; Nadia E Abou El-Ela; Soraya Sharaf; Ola El Sagheer; Sahar Selim; Hatem Tallima; Maaike J Bruins; Kevin B Hadley; Rashika El Ridi
Journal:  Am J Trop Med Hyg       Date:  2015-01-26       Impact factor: 2.345

7.  Treatment of Schistosoma mansoni with miltefosine in vitro enhances serological recognition of defined worm surface antigens.

Authors:  Marwa H El-Faham; Maha M Eissa; Joseph E Igetei; Eglal I Amer; Susan Liddell; Mervat Z El-Azzouni; Michael J Doenhoff
Journal:  PLoS Negl Trop Dis       Date:  2017-08-25

8.  Natural products as leads in schistosome drug discovery.

Authors:  Bruno J Neves; Carolina H Andrade; Pedro V L Cravo
Journal:  Molecules       Date:  2015-01-23       Impact factor: 4.411

9.  Developmental gene expression profiles of the human pathogen Schistosoma japonicum.

Authors:  Geoffrey N Gobert; Luke Moertel; Paul J Brindley; Donald P McManus
Journal:  BMC Genomics       Date:  2009-03-25       Impact factor: 3.969

Review 10.  Arachidonic acid: Physiological roles and potential health benefits - A review.

Authors:  Hatem Tallima; Rashika El Ridi
Journal:  J Adv Res       Date:  2017-11-24       Impact factor: 10.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.